Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $1.91 billion. The enterprise value is $1.74 billion.

Market Cap	1.91B
Enterprise Value	1.74B

Important Dates

The last earnings date was Tuesday, May 5, 2026, after market close.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

TRVI has 141.98 million shares outstanding. The number of shares has increased by 33.10% in one year.

Current Share Class	141.98M
Shares Outstanding	141.98M
Shares Change (YoY)	+33.10%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	79.70%
Float	117.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	10.02
P/TBV Ratio	11.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.75, with a Debt / Equity ratio of 0.00.

Current Ratio	24.75
Quick Ratio	24.30
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.59% and return on invested capital (ROIC) is -24.14%.

Return on Equity (ROE)	-33.59%
Return on Assets (ROA)	-23.01%
Return on Invested Capital (ROIC)	-24.14%
Return on Capital Employed (ROCE)	-30.59%
Weighted Average Cost of Capital (WACC)	10.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	34
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-73,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +106.62% in the last 52 weeks. The beta is 1.08, so TRVI's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+106.62%
50-Day Moving Average	13.08
200-Day Moving Average	11.08
Relative Strength Index (RSI)	43.92
Average Volume (20 Days)	1,584,653

Short Selling Information

The latest short interest is 15.29 million, so 10.77% of the outstanding shares have been sold short.

Short Interest	15.29M
Short Previous Month	16.14M
Short % of Shares Out	10.77%
Short % of Float	12.98%
Short Ratio (days to cover)	8.89

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.77M
Pretax Income	-45.68M
Net Income	-45.61M
EBITDA	-52.63M
EBIT	-52.77M
Earnings Per Share (EPS)	-$0.32

Balance Sheet

The company has $171.78 million in cash and $682,000 in debt, with a net cash position of $171.10 million or $1.21 per share.

Cash & Cash Equivalents	171.78M
Total Debt	682,000
Net Cash	171.10M
Net Cash Per Share	$1.21
Equity (Book Value)	172.13M
Book Value Per Share	1.34
Working Capital	169.01M

Cash Flow

In the last 12 months, operating cash flow was -$45.30 million and capital expenditures -$114,000, giving a free cash flow of -$45.42 million.

Operating Cash Flow	-45.30M
Capital Expenditures	-114,000
Depreciation & Amortization	141,000
Net Borrowing	n/a
Free Cash Flow	-45.42M
FCF Per Share	-$0.32

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.10%
Shareholder Yield	-33.10%
Earnings Yield	-2.39%
FCF Yield	-2.38%

Analyst Forecast

The average price target for TRVI is $23.45, which is 74.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.45
Price Target Difference	74.61%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2